Merck KGaA taps AI-focused biotech for new ADC pact worth $376M

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M

Source: 
Fierce Biotech
snippet: 

Merck KGaA is hoping to sprout some new oncology and immunology therapeutics with Biolojic Design’s AI-driven drug discovery engine.